Delivery Order SPE2DB20D3303-SPE2DB25FA3XW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units) valued at $1,979.60. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction. The order is scheduled for ultimate completion by September 16, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,431.02 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 40 mg capsules (30-count) with an ultimate completion date of September 11, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count packaging) with a ceiling value of $1,882.44. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 29, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of 1,000 units of Duloxetine HCL DR 60 mg capsules at a ceiling value of $1,433.94. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,170.96 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Duloxetine HCL DR 60 mg capsules (1,000 units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set for completion by September 2, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,919.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 1,000 capsules of Duloxetine HCL DR 20 mg. This non-set-aside contract, which is due for completion by August 13, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 1,000 units of Duloxetine HCL DR 60 mg capsules, valued at $1,046.72. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count packaging) with a ceiling value of $1,320.72. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The order has an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,376.36 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units). This contract utilizes a firm fixed-price structure and is not set aside for any particular business category. The award is classified as a delivery order, indicating it derives from an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- This delivery order, awarded on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides 1,000 capsules of Duloxetine HCl 60 mg under a firm fixed-price contract valued at $2,247.82. The order will be completed by August 29, 2025, and performed at the contractor's Conshohocken, Pennsylvania facility. This award represents a non-competitive delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3XWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Duloxetine HCL DR 20 mg capsules (1,000 count) valued at $2,926.02 with a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made on a non-set-aside, competitive basis, with performance required at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive DLA prime vendor contract. The SPE2DX vehicle enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This delivery order for Duloxetine—a neurological treatment medication—exemplifies the company's ongoing role in fulfilling federal defense healthcare supply requirements through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/19/25 |